A host protein network necessary for parasite cytolysis

寄生虫细胞溶解所需的宿主蛋白网络

基本信息

  • 批准号:
    8305183
  • 负责人:
  • 金额:
    $ 38.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-01 至 2017-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Intracellular pathogens from viruses to eukaryotes cause significant disease worldwide. An essential process in the life cycle of these pathogens is the ability to efficiently exit from host cells after intracelular replication. As opposed to the wll-characterized strategies of exit such as budding or apoptosis, this proposal will focus on how intracellular parasites utilize cytolysis as an exit strategy, the molecular details of which are poorly understood. Our prior studies led to the discovery that these two apicomplexans both use the calcium regulated host protease calpain in order to exit from their host cells. We hypothesize that intracellular cytolytic parasites utilize a complex set of calcium regulated host proteins for efficient egress. We will test this hypothesis using two Apicomplexan organisms, P. falciparum and T. gondii. Plasmodium sp., which causes malaria, is responsible for worldwide morbidity and mortality for which new therapies are urgently needed. Toxoplasma infection poses serious problems during congenital infection of humans, agriculturally important animals, and in immunocompromised adults. Plasmodium and Toxoplasma are obligate intracellular pathogens with similar virulent lytic cycles. During these lytic cycles parasites invade host cells and establish a specialized compartment within the host cell called the parasitophorous vacuole, within which they complete their entire intracellular cycle. After replication, daughter parasite cells must exit their host cell via lysis of both the vacuolar membrane and the host plasma membrane. We herein propose to integrate cell biological, molecular genetics, and pharmacological approaches to elucidate the activation, function, and significance of this host network for parasite cytolysis. PUBLIC HEALTH RELEVANCE: Intracellular pathogens, such as the malaria parasite P. falciparum, cause significant disease worldwide. An essential process in the life cycle of these pathogens is their ability to exit from host cells after intracelular replication. We hypothesize tat intracellular parasites utilize host proteins for exit. The findings from our proposed studies may be of use for the development of antiparasitics for multiple pathogens that may limit resistance.
描述(由申请方提供):从病毒到真核生物的细胞内病原体在全球范围内引起重大疾病。这些病原体生命周期中的一个重要过程是在细胞内复制后有效地离开宿主细胞的能力。相对于wll所描述的诸如出芽或凋亡的退出策略,该建议将关注细胞内寄生虫如何利用细胞溶解作为退出策略,其分子细节知之甚少。我们先前的研究发现,这两种顶复门都使用钙调节的宿主蛋白酶钙蛋白酶,以退出其宿主细胞。我们假设细胞内溶细胞寄生虫利用一组复杂的钙调节宿主蛋白, 有效的出口我们将使用两种顶复门生物,恶性疟原虫和T。刚地。疟原虫属,引起疟疾的疟疾是世界范围发病率和死亡率的原因,因此迫切需要新的治疗方法。弓形虫感染在人类、农业上重要的动物和免疫功能低下的成年人的先天性感染期间造成严重的问题。疟原虫和弓形虫是具有相似毒力溶解循环的专性胞内病原体。在这些裂解周期中,寄生虫侵入宿主细胞,并在宿主细胞内建立一个称为寄生虫空泡的专门区室,在其中完成整个细胞内周期。在复制之后,子寄生虫细胞必须通过液泡膜和宿主质膜两者的裂解离开它们的宿主细胞。我们在此建议整合细胞生物学,分子遗传学和药理学方法来阐明寄生虫细胞溶解的宿主网络的激活,功能和意义。 公共卫生相关性:细胞内病原体,如恶性疟原虫,在世界范围内引起重大疾病。这些病原体生命周期中的一个重要过程是它们在细胞内复制后离开宿主细胞的能力。我们假设细胞内寄生虫利用宿主蛋白质退出。我们提出的研究结果可能用于开发可能限制耐药性的多种病原体的抗寄生虫药。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Doron Greenbaum其他文献

Doron Greenbaum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Doron Greenbaum', 18)}}的其他基金

Cathepsin B Inhibitors as Therapeutics for Ebola Infection
组织蛋白酶 B 抑制剂治疗埃博拉感染
  • 批准号:
    8980049
  • 财政年份:
    2015
  • 资助金额:
    $ 38.87万
  • 项目类别:
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS
组织蛋白酶 L 抑制剂作为泛冠状病毒治疗药物
  • 批准号:
    9233899
  • 财政年份:
    2015
  • 资助金额:
    $ 38.87万
  • 项目类别:
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS
组织蛋白酶 L 抑制剂作为泛冠状病毒治疗药物
  • 批准号:
    9014497
  • 财政年份:
    2015
  • 资助金额:
    $ 38.87万
  • 项目类别:
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS
组织蛋白酶 L 抑制剂作为泛冠状病毒治疗药物
  • 批准号:
    8905856
  • 财政年份:
    2015
  • 资助金额:
    $ 38.87万
  • 项目类别:
A host protein network necessary for parasite cytolysis
寄生虫细胞溶解所需的宿主蛋白网络
  • 批准号:
    8415823
  • 财政年份:
    2012
  • 资助金额:
    $ 38.87万
  • 项目类别:
A host protein network necessary for parasite cytolysis
寄生虫细胞溶解所需的宿主蛋白网络
  • 批准号:
    8606155
  • 财政年份:
    2012
  • 资助金额:
    $ 38.87万
  • 项目类别:
Development of an activity based probe family for metallo aminopeptidases
开发基于活性的金属氨肽酶探针家族
  • 批准号:
    8134639
  • 财政年份:
    2010
  • 资助金额:
    $ 38.87万
  • 项目类别:
Plasmodium signal peptide peptidase as a novel antimalarial target
疟原虫信号肽肽酶作为新型抗疟靶点
  • 批准号:
    7913568
  • 财政年份:
    2009
  • 资助金额:
    $ 38.87万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 38.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了